NCT07251062 2025-11-26
A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 2/3 Not yet recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Chongqing University Cancer Hospital